Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and PD of Oral and Intranasal Oxycodone in Healthy Volunteers
NCT07223450Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Jun 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxycodone in pain (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Area Under the Curve at 24 hours, Time to Maximum Concentration at 24 hours and 1 more. Started Jun 2025; status: completed.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT07223450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223450.